Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. [electronic resource]
Producer: 19991122Description: 2901-10 p. digitalISSN:- 0006-4971
- Antibodies, Monoclonal -- pharmacology
- B-Lymphocytes -- chemistry
- Bacterial Toxins -- pharmacology
- Biomarkers
- Biomarkers, Tumor
- Blood Cells -- chemistry
- Bone Marrow Cells -- chemistry
- Bone Marrow Purging -- methods
- Breast Neoplasms -- chemistry
- Carcinoma -- chemistry
- Cell Separation -- methods
- Cells, Cultured
- Colony-Forming Units Assay
- Female
- Flow Cytometry
- Genes, Immunoglobulin
- Glycolipids -- analysis
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cells -- chemistry
- Humans
- Immunoglobulin Heavy Chains -- genetics
- Lymphoma, B-Cell -- chemistry
- Lymphoma, Follicular -- chemistry
- Male
- Multiple Myeloma -- metabolism
- Neoplasm Proteins -- analysis
- Neoplastic Stem Cells -- chemistry
- Organ Specificity
- Plasma Cells -- chemistry
- Receptors, Cell Surface -- analysis
- Reverse Transcriptase Polymerase Chain Reaction
- Shiga Toxin 1
- Transplantation, Autologous
- Trihexosylceramides -- analysis
- Tumor Cells, Cultured
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.